(ab7960) was used at 1:500. β-Actin antibody from Millipore, Billerica, MA (# MAB1501) at 1:5000 was used as a loading control.
Immunohistochemical analyses of tumors
The OCT-embedded tissues were cut onto the silanated glass slides at 15 Am thickness with cryostat, air dried, and stored at -80°C. To process for immunohistochemistry staining, the cryosections were thawed at room temperature for 30 min. Serial frozen sections were fixed with 4% paraformaldehyde/phosphate buffered saline (PBS) at 4°C for 15 minutes. Slides were incubated in a 0.2% triton X-100/PBS solution for 5 minutes at room temperature for membrane permeation. Nonspecific binding sites were blocked with 5.5% serum (of secondary antibody host species)/tris buffered saline (TBS) and endogenous tissue peroxidase was quenched with a 0.6% H2O2/TBS solution. Excess solution was discarded and the sections were incubated with the first primary antibody in blocking solutions at 4°C overnight. After washing with PBS, the slides were sequentially incubated with the biotinylated secondary antibody (1:400; Vector Laboratories) for 1 h followed by avidin-biotin complex (Vector Labs, Burlingame, CA).
Immune complexes were revealed via incubation with 3, 3'-(FASTDAB tablet; Sigma, St. Louis, MO) under microscopic control. The reaction was stopped in tap water, and the tissues were counterstained with hematoxylin, dehydrated through graded alcohols, cleared with xylenes, and mounted using Permount (Fisher, Waltham, MA). Whole slide images were acquired using an Aperio Scanscope at 200X magnification. Relevant areas were quantified as histological score using the Aperio Cell Quantification Software (Aperio, Vista, CA), and expressed as the percentage of positive cells with respect to the total number of cells in each histologically defined area. The following antibodies were used for immunostaning: p-Akt (S129) antibody (AP3020a, ABGENT, San Diego, CA). The following antibodies are from Cell Signaling: p-Akt (S473) antibody (#3787), and pAkt (308) antibody (#2965) p-Erk1/2 (Thr202/Tyr204) antibody (#4370) p-p65 S536 (#3033), p-S6 S240/244 (#5364), BCL-XL (#2764) at 1:100 dilution. The following antibodies are from Abcam, anti-p-p65 S529 (ab47395) at 1:100), anti-BAX (ab7977) at 1:100 dilution, JunB (ab31421) at 1:250, and FosL-1 (ab117951) at 1:50. Anti-Ki-67 (TEC-3) antibody (DAKO, Glostrup, Denmark) was used at 1:500; anti-TP53 (FL-393) antibody was from Santa Cruz, using manufacturer's condition.
Deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay
Apoptotic cells in tumor tissues were quantified by the terminal deoxynucleotidyl transferasemediated dUTP nick end labeling (TUNEL), using the in situ cell death detection kit, POD UM-SCC lines (University of Michigan series of head and neck squamous cell carcinoma) and clinical information were provided by Drs. Thomas E Carey, and from previous publications. TNM, tumor-node-metastasis (staging system); Primary sites, the origin of the primary tumor; Rec, recurrence; Prior therapy, therapy given before the specimen used for culture was obtained; Survival, time in months from diagnosis to last follow up; FOM, floor of mouth; BOT, base of tongue; LN, lymph nodes; R, radiation; S, surgery; C, chemotherapy; N, no treatment; DOD, died with disease; DWOD, died without disease; LTF, lost to follow-up; NED: no evidence of disease; AWD: alive with disease. NA: not available.
